ClinicalTrials HQ

InventisBio Co., Ltd

InventisBio Co., Ltd

Explore linked clinical trials.

16 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic FunctionHealthy Adult Participants; Hepatic Impairment (HI)RecruitingPhase 12026-09-23NCT07715149
A Study to Evaluate YF087 in Subjects With MSI-H or dMMR Advanced Solid TumorsAdvanced Solid Tumor CancerNot yet recruitingPhase 12026-09-09NCT07809607
The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function.Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorderNot yet recruitingPhase 12026-07-23NCT07715175
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative ColitisDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisActive, not recruitingPhase 22026-07-17NCT07035041
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid TumorsSolid TumorActive, not recruitingPhase 1 / Phase 22026-07-17NCT05379946
Study of D-2570 in Subjects With Non-Segmental VitiligoSkin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligoRecruitingPhase 22026-07-15NCT07625891
Healthy Volunteer StudyHealthy VolunteerActive, not recruitingPhase 12026-07-14NCT07270783
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderRecruitingPhase 22026-07-09NCT07489885
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid TumorsSolid TumorActive, not recruitingPhase 1 / Phase 22026-07-02NCT06166836
Mass Balance Study of [14C] D-2570Mass Balance StudyActive, not recruitingPhase 12026-04-29NCT07411742
A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque PsoriasisPlaque PsoriasisRecruitingPhase 32026-04-29NCT07326813
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)Active Systemic Lupus ErythematosusRecruitingPhase 22026-04-24NCT07311200
A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic ArthritisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorderRecruitingPhase 22026-04-22NCT07315061
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-03-31NCT06954961
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque PsoriasisPlaque PsoriasisRecruitingPhase 32025-12-09NCT07130604
Study to Evaluate D-1553 in Subjects With Solid Tumorscolorectal carcinoma, non-small cell lung carcinomaActive, not recruitingPhase 1 / Phase 22025-03-18NCT04585035